Nov 27Anavex Life Sciences Reports Fiscal 2023 Year End Financial Results and Provides Business Update
Nov 24Anavex Life Sciences to Announce Fiscal 2023 Year End Financial Results on Monday, November 27, 2023
Sep 12Anavex Announces Appointment of Dr Marwan N Sabbagh, MD as Chairman of the Scientific Advisory Board
Jun 28Long-term Clinical Study Demonstrates Disease-Modifying Effects of ANAVEX®2-73 for Rett Syndrome
Jun 12Anavex Life Sciences Reports Publication in Medical Journal for Continued Commitment to Improve RSBQ
May 2Anavex Life Sciences to Announce Fiscal 2023 Second Quarter Financial Resultson Tuesday May 9, 2023
Mar 30ANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in Long-Term 48Week Phase 2 Extension Study in PDD
Mar 9Anavex Life Sciences Appoints Former FDA Lead Neurology Statistician as VP Head of Biostatistics